Co-CEOs Chintu and Chirag Patel (Amneal)
Look out, Neulasta: A 5th biosimilar is coming
As Neulasta sales slip, Amgen has yet another biosimilar to look out for: Amneal Pharmaceuticals and Kashiv Biosciences’ Flynetra.
Flynetra became the fifth approved biosimilar …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
